Firmaet fremlagde dokumentation for, at blodets indhold af de aktive stoffer var det samme hos patienter, der tog Tandemact, og patienter, der tog særskilte tabletter.
The company provided evidence that the levels of the active substances in the blood were the same in people taking Tandemact and people taking the separate tablets.